No.2
公告
2026/10/20 19:04
その他
VOLUNTARY ANNOUNCEMENT - UTD2 OF BIOSTAR ACHIEVES FIRST PATIENT DOSING IN PHASE III CLINICAL STUDY FOR HER2-NEGATIVE ADVANCED BREAST CANCER
VOLUNTARY ANNOUNCEMENT - UTD2 OF BIOSTAR ACHIEVES FIRST PATIENT DOSING IN PHASE III CLINICAL STUDY FOR HER2-NEGATIVE ADVANCED BREAST CANCER